Suppliers / Kai Yuen Pharmaceutical

Kai Yuen Pharmaceutical

Hong Kong Updated 9 July 2026

Kai Yuen Pharmaceutical is a finished-dose manufacturer based in Hong Kong. It appears in 74 regulatory filings across 1 regulator, without an active US DMF or CEP on file.

0
active US DMFs
0
valid CEPs
0
registered plants
74
filings across 1 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
DH (HK) 74 None

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Questions about Kai Yuen Pharmaceutical

Does Kai Yuen Pharmaceutical hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Kai Yuen Pharmaceutical. It does have 74 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Kai Yuen Pharmaceutical file?
Filings are on record with DH (HK), 74 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Kai Yuen Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability